KCNK2 and migraine disorder: In elegant studies, the same authors describe a mechanism by which the migraine-associated frameshift mutation (F139WfsX24) leads to production of a novel secondary protein product that selectively inhibits TREK1/2 channels and proposed that this effect of the mutation underlies migraine pathogenicity.